View in EDS HTML Full Text PDF Full Text

Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.

Saved in:
Bibliographic Details
Title: Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.
Authors: Kulasekararaj A; King's College Hospital NHS Foundation Trust, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, UK., Lanza F; Hematology Unit, Hospital of Ravenna, University of Bologna, Bologna, Italy., Arvanitakis A; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Oncology and Radiation Physics, Skane University Hospital, Malmo, Sweden., Langemeijer S; Department of Hematology, Radboud Universitair Medisch Centrum, Nijmegen, The Netherlands., Chonat S; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Tombak A; Internal Medicine - Hematology Department, Mersin University, Mersin, Turkey., Hanes V; Amgen Inc, Thousand Oaks, California, USA., Cao J; Amgen Inc, Thousand Oaks, California, USA., Miller MJ; Amgen Inc, Thousand Oaks, California, USA., Colbert A; Amgen Inc, Thousand Oaks, California, USA., Shander B; Amgen Inc, Thousand Oaks, California, USA., Mytych DT; Amgen Inc, Thousand Oaks, California, USA., Chow V; Amgen Inc, Thousand Oaks, California, USA., Henary H; Amgen Inc, Thousand Oaks, California, USA.
Source: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2108-2117. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39171864
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kulasekararaj+A%22">Kulasekararaj A</searchLink>; King's College Hospital NHS Foundation Trust, National Institute of Health Research/Wellcome King's Clinical Research Facility and King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Lanza+F%22">Lanza F</searchLink>; Hematology Unit, Hospital of Ravenna, University of Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Arvanitakis+A%22">Arvanitakis A</searchLink>; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Haematology, Oncology and Radiation Physics, Skane University Hospital, Malmo, Sweden.<br /><searchLink fieldCode="AU" term="%22Langemeijer+S%22">Langemeijer S</searchLink>; Department of Hematology, Radboud Universitair Medisch Centrum, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chonat+S%22">Chonat S</searchLink>; Department of Pediatrics, Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Tombak+A%22">Tombak A</searchLink>; Internal Medicine - Hematology Department, Mersin University, Mersin, Turkey.<br /><searchLink fieldCode="AU" term="%22Hanes+V%22">Hanes V</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Cao+J%22">Cao J</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Miller+MJ%22">Miller MJ</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Colbert+A%22">Colbert A</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Shander+B%22">Shander B</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Mytych+DT%22">Mytych DT</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Chow+V%22">Chow V</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Henary+H%22">Henary H</searchLink>; Amgen Inc, Thousand Oaks, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227610369%22">American journal of hematology</searchLink> [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2108-2117. <i>Date of Electronic Publication: </i>2024 Aug 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Comparative Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7610369 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203618609%22">03618609 </searchLink><i>NLM ISO Abbreviation: </i>Am J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39171864
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ajh.27456
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2108
    Titles:
      – TitleFull: Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kulasekararaj A
      – PersonEntity:
          Name:
            NameFull: Lanza F
      – PersonEntity:
          Name:
            NameFull: Arvanitakis A
      – PersonEntity:
          Name:
            NameFull: Langemeijer S
      – PersonEntity:
          Name:
            NameFull: Chonat S
      – PersonEntity:
          Name:
            NameFull: Tombak A
      – PersonEntity:
          Name:
            NameFull: Hanes V
      – PersonEntity:
          Name:
            NameFull: Cao J
      – PersonEntity:
          Name:
            NameFull: Miller MJ
      – PersonEntity:
          Name:
            NameFull: Colbert A
      – PersonEntity:
          Name:
            NameFull: Shander B
      – PersonEntity:
          Name:
            NameFull: Mytych DT
      – PersonEntity:
          Name:
            NameFull: Chow V
      – PersonEntity:
          Name:
            NameFull: Henary H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2024 Nov
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1096-8652
          Numbering:
            – Type: volume
              Value: 99
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: American journal of hematology
              Type: main
ResultId 1